Navigation Links
Cardiome Reports First Quarter Results
Date:5/13/2008

NASDAQ: CRME TSX: COM

VANCOUVER, May 13 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported financial results for the first quarter ended March 31, 2008. Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP). At close of business on March 31, 2008, the exchange rate was CAD$1.00=US$0.9742.

Results of Operations

We recorded a net loss of $22.2 million ($0.35 per common share) for the three months ended March 31, 2008 ("Q1-2008"), compared to a net loss of $14.0 million ($0.23 per common share) for the three months ended March 31, 2007 ("Q1-2007"). The increase in net loss for the current quarter was largely due to lower licensing and research collaborative fees and increased research and development expenditures related to vernakalant (oral) and GED-aPC clinical activities.

Revenue for Q1-2008 was $0.4 million, a decrease of $1.3 million from $1.7 million in Q1-2007. Revenue in Q1-2008 consisted of $0.2 million (Q1-2007 - $0.4 million) in licensing fees and $0.2 million (Q1-2007 - $1.3 million) in research and collaborative fees.

Research and development expenditures were $18.1 million for Q1-2008 compared to $11.8 million for Q1-2007. General and administration expenses decreased to $4.1 million in Q1-2008 from $4.6 million in Q1-2007. Amortization was $1.1 million for Q1-2008 compared to $0.5 million for Q1-2007. Interest and other income was $0.3 million for Q1-2008 compared to $1.4 million for Q1-2007. Foreign exchange gain was $0.3 million for Q1-2008 compared to a loss of $0.2 million in Q1-2007.

Stock-based compensation, a non-cash item included in operating expenses, decreased to $1.0 million for Q1-2008, as compared to $1.5 million for Q1-2007.

Liquidity and Outstanding Share Capital

As of March 31, 2008, the Company had cash and cash
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cardiome to Present at Bear Stearns Conference
2. Cardiome to Present at ThinkEquity Conference
3. Cardiome to Present at CIBC Conference
4. Cardiome To Release Third Quarter Results
5. Cardiome Initiates Phase 1 Study for GED-aPC
6. Cardiome Updates Guidance
7. Cardiome to Hold Investor Update Call
8. Cardiome And Astellas Announce Regulatory Update
9. Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
10. Cardiome To Release 2007 Results
11. Cardiome To Release 2008 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 04, 2015 Parkview Regional Hospital ... Alan Daugherty has been named chief executive officer ... served as interim CEO of Parkview Regional and ... provided tremendous leadership during his tenure as interim ... strategy and developing relationships with physicians, patients and ...
(Date:3/4/2015)... Nurses, healthcare professionals and the general public ... to learn about why cannabis is a safe and ... conditions. The one-day continuing education (CE) seminar, “ACNA Core ... 1 or April 2 at Aloft Cleveland Downtown. ... Nurses Association (OBN-001-91), an accredited approver by the American ...
(Date:3/3/2015)... Washington, DC (PRWEB) March 04, 2015 ... business into value-based payment contracts within the next few ... — and the significant chunk of health care spending ... Information Services, Inc.’s ACO Business News (ABN) tracks ... the context of a commercial accountable care organization (ACO)-type ...
(Date:3/3/2015)... On February 24, 2015, a Toledo, Ohio homeowner ... Court for the Northern District of Ohio against mortgage ... companies Balboa, QBE, and Newport Management. (See Amended Complaint ... The Plaintiff, a Ms. Dolores Gorsuch, says her mortgage ... buy too much insurance at rates that were too ...
(Date:3/3/2015)... 03, 2015 Risperdal lawsuits ( ... the atypical antipsychotic medication continue to move forward ... documents, the South Carolina Supreme Court upheld a ... Johnson’s Janssen Pharmaceuticals unit had deceptively marketed the ... the Court’s February 25th decision characterized the company’s ...
Breaking Medicine News(10 mins):Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 2Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 3Health News:American Cannabis Nurses Association Announces Speaker Lineup for Educational Seminar in Cleveland 2Health News:American Cannabis Nurses Association Announces Speaker Lineup for Educational Seminar in Cleveland 3Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 2Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 3Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3
... and laparoscopic surgery found few differences in outcome , ... for men with prostate cancer whether they have open ... , Currently, open radical prostatectomy (ORP) is considered the ... (LRP), with or without robotic assistance, is becoming more ...
... ... ... ... ...
... ... technology products to the Japan market. OEM partners of the RDX storage technology include industry ... , ... -- The RDX® Storage Alliance today announced that Maxell , a technology ...
... ... by 60 Percent , ... Atlanta, GA (PRWEB) February 22, 2010 -- CustomerCentric Selling® (CCS), a proven methodology ... mailing industry leader for over 30 years in providing products and services for all ...
... ... sponsored by Horst Construction, senior living executives will learn about profitable new strategies, especially in ... communities. , ... 22, 2010 -- The 9th Annual Senior Living Conference sponsored by Horst Construction will be ...
... ATLANTA--A new study has found that many male cancer ... radiation therapy have an impaired quality of life and ... , a peer-reviewed journal of the American Cancer Society, ... testosterone deficiency may benefit from testosterone replacement therapy. ...
Cached Medicine News:Health News:WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility 2Health News:WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility 3Health News:WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility 4Health News:WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility 5Health News:WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility 6Health News:Maxell Joins RDX Storage Alliance to Support Growing Storage Professionals' Community 2Health News:Maxell Joins RDX Storage Alliance to Support Growing Storage Professionals' Community 3Health News:CustomerCentric Selling Helps BCC Software Dramatically Boost Sales Performance and Produce Record Results 2Health News:CustomerCentric Selling Helps BCC Software Dramatically Boost Sales Performance and Produce Record Results 3Health News:Register Online for this Year's Horst Senior Living Conference on April 8 Featuring Keynote Speaker and Senior Housing Expert Jim Moore 2
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/tbjpmj/blister_packaging ) ... Market in the US 2015-2019" report to their ... the US to grow at a CAGR of 6.11% ... form of high-visibility packaging that uses pre-formed plastic packs ... a base layer, made either of plastic or aluminum, ...
(Date:3/3/2015)... --  Surefire Medical, Inc. today announced the ... Infusion System with an end hole microcatheter.  In ... using the Surefire resulted in statistically significant increases ... significantly decreased uptake in normal liver tissue. The ... of Interventional Radiology (SIR) meeting in ...
(Date:3/3/2015)... PARIS , March 3, 2015 ... enrolled 356 and 240 patients respectively Publications ... Journal of Clinical Gastroenterology highlight diagnostic value ... in China and across ... Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, ...
Breaking Medicine Technology:United States Blister Packaging Market 2015-2019 - Growing Demand in Pharmaceuticals Industry with Amcor, Bemis, MeadWestvaco & Sonoco Products Dominating 2Clinical Trial Comparing the Surefire Infusion Device to an End Hole Catheter Finds Surefire Increases Tumor Uptake and Decreases Non-Target Embolization In Every Patient, Multiple Liver Cancer Types 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 3Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 4
... Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of ... neuro-otologic, vestibular and neurological testing, said today that ... control and analysis software. Clinical specialists ... conduct vestibular, oculomotor and optokinetic tests to detect ...
... of Wolters Kluwer Health and ... for the medical, scientific, and academic markets, is pleased to announce ... the first clinical tool from Ovid designed especially for physicians ... on relevant full-text content from Ovid. It,s the only solution that ...
Cached Medicine Technology:Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software 2Ovid Announces its First Clinical Tool, OvidMD, Designed for Physicians and Other Clinicians 2Ovid Announces its First Clinical Tool, OvidMD, Designed for Physicians and Other Clinicians 3Ovid Announces its First Clinical Tool, OvidMD, Designed for Physicians and Other Clinicians 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: